Table 1. RPN2 expression and clinicopathological factors.
Factors | RPN2 expression | P-value | ||
---|---|---|---|---|
positive 19 | negative 21 | |||
Age | 70≧ | 4 | 7 | P = 0.488 |
70< | 15 | 14 | ||
Sex | male | 14 | 17 | P = 0.583 |
female | 5 | 4 | ||
cT | T3(SS) | 3 | 4 | P = 0.557 |
T4a(SE) | 15 | 17 | ||
T4b(SI) | 1 | 0 | ||
cN | N0 | 2 | 1 | P = 0.897 |
N1 | 6 | 6 | ||
N2 | 7 | 9 | ||
N3 | 4 | 5 | ||
cM | absent | 14 | 12 | P = 0.333 |
present | 5 | 9 | ||
cStage | IIB | 3 | 0 | P = 0.392 |
IIIA | 5 | 5 | ||
IIIB | 5 | 4 | ||
IIIC | 1 | 3 | ||
IV | 5 | 9 | ||
Macroscopic | Type 2 | 5 | 9 | P = 0549 |
type | Type 3 | 7 | 6 | |
Type 4 | 7 | 6 | ||
Histological | differentiated | 2 | 9 | P = 0.034 |
type | undifferentiated | 17 | 12 | |
Treatment after DCS | gastrectomy | 15 | 16 | P = 0.749 |
Continue DCS, and subsequent gastrectomy | 4 | 5 |
Abbreviations: DCS = docetaxel combined with S-1 and cisplatin; RPN2 = ribophorin II. Analyzed by Fisher's exact test.